These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 1903329)

  • 1. [Costs and benefits of screening for colorectal tumors using the Hemoccult test in asymptomatic individuals 45-60 years of age].
    Fric P; Zoubek V; Dvoráková H; Roth Z
    Cas Lek Cesk; 1991 Mar; 130(12):370-3. PubMed ID: 1903329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An adapted program of colorectal cancer screening--7 years experience and cost-benefit analysis.
    Fric P; Zavoral M; Dvoráková H; Zoubek V; Roth Z
    Hepatogastroenterology; 1994 Oct; 41(5):413-6. PubMed ID: 7851847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Results of screening for colorectal carcinoma in the Bruntál District using the Haemoccult Test 1985-1986].
    Zoubek V; Zoubková H
    Cas Lek Cesk; 1989 Apr; 128(15):460-2. PubMed ID: 2736587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of screening for colorectal carcinoma in the District of Bruntál using the Haemoccult Test in 1985-1988.
    Zoubek V; Zoubková H
    Czech Med; 1990; 13(2-3):52-7. PubMed ID: 2245757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Repeat screening for colorectal carcinoma in a population of asymptomatic individuals after 2 years].
    Zoubek V; Zoubková H
    Cas Lek Cesk; 1989 Apr; 128(15):463-4. PubMed ID: 2736588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Earlier stages of colorectal cancer detected with immunochemical faecal occult blood tests.
    van Rossum LG; van Rijn AF; van Munster IP; Jansen JB; Fockens P; Laheij RJ; Dekker E
    Neth J Med; 2009 May; 67(5):182-6. PubMed ID: 19581668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Population screening for colorectal carcinoma by examining feces for occult hemorrhage].
    Musil D
    Vnitr Lek; 1999 Aug; 45(8):496-9. PubMed ID: 11045153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The detection of colorectal cancer at an asymptomatic stage by screening is useful.
    Komuta K; Furui J; Haraguchi M; Kanematsu T
    Hepatogastroenterology; 2000; 47(34):1011-4. PubMed ID: 11020866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonmedical costs of colorectal cancer screening with the fecal occult blood test and colonoscopy.
    Heitman SJ; Au F; Manns BJ; McGregor SE; Hilsden RJ
    Clin Gastroenterol Hepatol; 2008 Aug; 6(8):912-917.e1. PubMed ID: 18534918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal cancer screening with faecal occult blood test within a multiple disease screening programme: an experience from Keelung, Taiwan.
    Yang KC; Liao CS; Chiu YH; Yen AM; Chen TH
    J Med Screen; 2006; 13 Suppl 1():S8-13. PubMed ID: 17227635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of and suitability of the occult fecal blood test in a preventive program for colorectal carcinoma].
    Ebling Z; Hadzić N
    Lijec Vjesn; 1989 Dec; 111(12):432-6. PubMed ID: 2636303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occult-blood screening for colorectal carcinoma: the yield and the costs.
    Frank JW
    Am J Prev Med; 1985; 1(5):18-24. PubMed ID: 3939711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer.
    Lindholm E; Brevinge H; Haglind E
    Br J Surg; 2008 Aug; 95(8):1029-36. PubMed ID: 18563785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal cancer screening for the natural population of Beijing with sequential fecal occult blood test: a multicenter study.
    Li S; Nie Z; Li N; Li J; Zhang P; Yang Z; Mu S; Du Y; Hu J; Yuan S; Qu H; Zhang T; Wang S; Dong E; Qi D
    Chin Med J (Engl); 2003 Feb; 116(2):200-2. PubMed ID: 12775229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for gastrointestinal neoplasia: efficacy and cost of two different approaches in a clinical rehabilitation centre.
    Manus B; Brägelmann R; Armbrecht U; Stolte M; Stockbrügger RW
    Eur J Cancer Prev; 1996 Feb; 5(1):49-55. PubMed ID: 8664809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population colorectal cancer screening with fecal occult blood test.
    Rennert G; Rennert HS; Miron E; Peterburg Y
    Cancer Epidemiol Biomarkers Prev; 2001 Nov; 10(11):1165-8. PubMed ID: 11700264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic evaluation of colorectal cancer screening with fecal occult blood detection.
    Tárraga López PJ; Marín Nieto E; Celada Rodríguez A; García Molinero MJ; García Olmo D; Solera Albero J
    Rev Esp Enferm Dig; 2000 May; 92(5):334-48. PubMed ID: 10927933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Problems in the early diagnosis and treatment of colorectal carcinoma and adenoma in the aged].
    Zoubek V; Zoubková H; Mrůzek M
    Vnitr Lek; 1990 Oct; 36(10):998-1001. PubMed ID: 2256262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Performance of the Hemoccult test in the screening of colorectal cancer and adenoma. Results of 5 screening campaigns in Saône-et-Loire].
    Tazi MA; Faivre J; Lejeune C; Benhamiche AM; Dassonville F
    Gastroenterol Clin Biol; 1999 May; 23(5):475-80. PubMed ID: 10429850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.